Across TCGA pan-cancer cohorts, RNA5SP198 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNA5SP198 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher RNA5SP198 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP198 expression acts as an unfavorable survival marker.
KICH, MESO, and DLBC are the cancer types where RNA5SP198 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.